Bob Liu

Bob Liu is currently a Principal Scientist at Genentech, a position held since 2022. Prior to this role, Bob completed extensive postdoctoral research at UCSF and Genentech. Bob earned a Ph.D. in Oncology and Cancer Biology from the University of Wisconsin-Madison and has held various scientific positions, including Scientist II at Cellerant Therapeutics and Stem CentRx, and Senior Scientist at both CytomX Therapeutics and Amunix. Bob also holds a Bachelor's degree in Biochemistry from the University of California, Berkeley.